Contact Us
|
PRODUCTS & SERVICES
Antibody Products
Antibody Products Store
Neuroscience
Epitope Tags
Structural Proteins & Cell Components
Signal Transduction
Immunopathology
Detection Chemistries & Ancillaries
Biopharmaceutical Services
Biorepository Services
Nonclinical Services
Antibody Products
Bioanalytical
Discovery
Drug Metabolism & Pharmacokinetics
Immunology
Pharmaceutical Analysis
Research Models
Safety Pharmacology
Toxicology
Clinical Services
Bioanalytical
Central Laboratory
Clinical Development (Phase I-III)
Pharmaceutical Analysis
Commercialization Services
Market Access
Periapproval (Phase IIIb-IV)
Integration in Drug Development
Strategic Partnering
Biomarker Center of Excellence
Secure Data Access
Environmental Sciences
Nutritional Chemistry & Food Safety
CAREERS
Search Jobs
CARE Rwanda
College / University
Featured Jobs
Diversity
Leadership
Working at Covance
Agency Login
INVESTORS
Investor Information
Investor Home
Stock Information
Board of Directors
Corporate Governance Guidelines
Analyst Coverage
Investor FAQ
Presentations & Webcasts
Financial Information
SEC Filings
Annual Reports
Press Releases
Calendar of Events
Request Information
NEWS
Press Releases
Media Relations
ABOUT COVANCE
Company Overview
Industry Overview
History of Covance
Mission & Vision
Executive Leadership
Global Locations
Animal Welfare
RESOURCE CENTER
Investors
Investor Information
Investor Home
Stock Information
Board of Directors
Corporate Governance Guidelines
Analyst Coverage
Investor FAQ
Presentations & Webcasts
Financial Information
Calendar of Events
Request Information
Home
> Investors >
Investor Information
Investor Relations
Investor Information
CVD
Exchange
NYSE (US Dollar)
Price
$39.24
Change (%)
0.49 (1.26)
Volume
767,223
Data as of Sep 3 2010 4:00PM
Minimum 20 minute delay
Annual Meeting Documents
2010 Proxy Statement
2009 Annual Report
Upcoming & Current Events
There are currently no events scheduled.
Recent Covance News
More
>>
Date
Title
28-Jul-2010
Covance Reports Second Quarter Revenue of $475M and EPS of $0.49; Updates Full-Year Financial Targets
Print
07-Jul-2010
Covance Inc. Invites You to Join the Webcast of Its Second Quarter 2010 Financial Results Conference Call
Print
14-Jun-2010
Covance to Present at William Blair & Company's 30th Annual Growth Stock Conference
Print
08-Jun-2010
Covance Expands Service Offerings With New Biorepository Facility
Print
Home
|
Animal Welfare
|
Privacy Policy
|
Contact Us
|
Site Map
|
Study Participants
|
Investigators
|
Email Signup
RSS
© Copyright 2010 Covance Inc. All rights reserved.